Most nations falling short of UN targets to cut premature deaths from chronic diseases
People in the UK, US and China have a higher risk of dying early from conditions like cancer, heart disease and stroke than people in Italy, France, South Korea and Australia.
These are the findings of the most detailed global analysis of deaths from so-called non-communicable disease (NCDs) – chronic conditions including cancer, cardiovascular disease, chronic respiratory disease, and diabetes.
The research, led by Imperial College London, World Health Organization and NCD Alliance, reveals that a 30-year-old woman in the UK has a 9 per cent chance of dying from four key NCDs – cancer, cardiovascular disease (which includes heart disease and stroke), chronic respiratory disease and diabetes – before her 70th birthday, compared to a 12 per cent chance for a woman living in the US, and 6 per cent for a woman living in Japan. Meanwhile a 30-year-old man living in the UK has a 13 per cent chance of dying from an NCD before age 70, compared to 11 per cent for a man living in Switzerland, and 18 per cent for a man living in the US.
The analysis, published in The Lancet, also revealed the majority of the world's nations – including the UK, US and China – look likely to fall short of the United Nations (UN) target for reducing the number of premature deaths from NCDs.
Professor Majid Ezzati, from Imperial’s School of Public Health, who led the study, said: “Non-communicable diseases are the main cause of premature death for most countries. Poverty, uncontrolled marketing of alcohol and tobacco by multinational industries, and weak health care systems are making chronic diseases a larger danger to human health than traditional foes such as bacteria and viruses.”
Sandeep P. Kishore, MD, PhD, MSc, Associate Director of the Arnhold Institute for Global Health Assistant Professor in the Department of Medicine and the Department of Health System Design and Global Health at the Icahn School of Medicine at Mount Sinai, who was involved in the study explained: “This analysis confirms that NCDs are the social justice issue of this generation - and must be treated as such. People should not be punished based on where they live and deserve stronger policies and national protections to ensure longer, healthier, fuller lives. NCD Countdown 2030 provides an essential platform for the world to monitor promises made by heads of state at the UN General assembly."
Too many people dying too soon
Non-communicable diseases kill nearly 41 million people a year, making up seven out of ten deaths globally, 17 million of these deaths are classed as premature (i.e. before the age of 70).
The new research is published ahead of a key UN meeting on NCDs next week. In 2015, the UN set the goal of a one-third reduction in premature deaths (between the ages of 30 and 70 years) from four key NCDs – cancer, cardiovascular disease, chronic respiratory disease, and diabetes – by the year 2030.
The group behind this research, who are collectively known as NCD Countdown 2030, warn that their findings suggest the UN target will be missed in all but 35 nations for women and 30 nations for men.
The study also reveals men and women in most countries around the world have a higher risk of dying prematurely from NCDs than from infectious diseases such as malaria or HIV.
US, UK and China falling short
The researchers analysed data on deaths from NCDs for more than 180 nations. Their findings revealed the lowest risks of dying early from NCDs were seen in high income countries, especially in South Korea, Japan, Switzerland and Australia.
But other high-income countries are lagging behind the leaders, including the UK (which ranks 17th for men, 27th for women), the US (53rd for men, 44th for women) and China (80th for men, 76th for women).
Overall, women in South Korea, Japan, Spain and Switzerland were least likely to die prematurely from the four key NCDs. The countries with the lowest risk for men were Iceland, Switzerland, Sweden and Norway.
In contrast, men in central Asia (Mongolia, Kazakhstan) and eastern Europe (Russia, Belarus) were among the most likely to die from the four key NCDs before the age of 70. For women, parts of sub-Saharan Africa (Sierra Leone, Côte d’Ivoire), Guyana, Afghanistan, Yemen and Papua New Guinea were among those with the greatest risk of premature death from the four key NCDs.
The study reveals that only 35 countries are on track to meet the UN target for women and only 30 countries for men.
Some of those countries on track to meet the UN target for both men and women include Denmark, New Zealand, Norway and South Korea, as well as Brazil, Iran and some of the high-risk eastern European countries. By comparison, the UK, Australia, France, Germany, India and China will fail to hit the target for both sexes.
The authors say if NCD deaths decline slightly faster in a further 50 countries (for women) and 35 countries (for men), they too would achieve the target.
According to the analysis, the situation is deteriorating or stagnating in 15 countries for women, including the US, and 24 for men.
Katie Dain, from the NCD Alliance, said: “We are sleepwalking into a sick future because of severely inadequate progress on non-communicable diseases. Post the UN High Level Meeting, NCD Countdown 2030 will assist in holding governments and donors accountable and help to ensure that the opportunity before us next week to renew, reinforce, and enhance commitments to reducing the burden of NCDs, translates the rhetoric into reality.”
Solutions to help countries reduce deaths
Professor Ezzati explained: “While much of the world is falling short of the UN target to alleviate the burden of chronic diseases, dozens of countries could meet this goal with modest acceleration of already-favourable trends. This requires national governments and international donors to invest in the right set of policies.”
Professor Ezzati added: “Treatment of hypertension and controlling tobacco and alcohol use alone can prevent millions of deaths from cancer, heart disease, stroke and other NCDs. But there is also a need for affordable high-quality care to diagnose and treat chronic diseases as early as possible.”
The team points out the findings are limited by the available data, citing major gaps in the completeness and accuracy of data in some countries. They explain that improving death registration in countries could improve accuracy.
James Bennett, the lead author of the study from the School of Public Health, said: “It’s important that international aid agencies and governments are held to account for their commitments to global targets for health. Improving the quality of health data from countries will help us identify which countries are performing best in reducing deaths from chronic diseases, as well as those that need additional help.”
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest integrated delivery system encompassing seven hospital campuses, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai's vision is to produce the safest care, the highest quality, the highest satisfaction, the best access and the best value of any health system in the nation. The System includes approximately 6,600 primary and specialty care physicians; 10 joint-venture ambulatory surgery centers; more than 140 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report's "Best Medical Schools", aligned with a U.S. News & World Report's "Honor Roll" Hospital, No. 13 in the nation for National Institutes of Health funding, and among the top 10 most innovative research institutions as ranked by the journal Nature in its Nature Innovation Index. This reflects a special level of excellence in education, clinical practice, and research. The Mount Sinai Hospital is ranked No. 18 on U.S. News & World Report's "Honor Roll" of top U.S. hospitals; it is one of the nation's top 20 hospitals in Cardiology/Heart Surgery, Gastroenterology/GI Surgery, Geriatrics, Nephrology, and Neurology/Neurosurgery, and in the top 50 in six other specialties in the 2018-2019 "Best Hospitals" issue. Mount Sinai's Kravis Children's Hospital also is ranked nationally in five out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 11th nationally for Ophthalmology and 44th for Ear, Nose, and Throat, while Mount Sinai Beth Israel, Mount Sinai St. Luke's and Mount Sinai West are ranked regionally.